The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Dale W. Garsed(Peter MacCallum Cancer Centre), David D.L. Bowtell(The University of Melbourne), Kazuaki Takahashi(Tokyo Shinagawa Hospital), Julie M. Cunningham(Cancer Research UK), Nicholas W. Bateman(Inova Health System), Flurina A.M. Saner(University of Bern), G. Larry Maxwell(Inova Health System), Bronwyn Grout(UNSW Sydney), Ellen L. Goode(Mayo Clinic in Arizona), Bryan M. McCauley(University of Minnesota), Michael Friedländer(Prince of Wales Hospital), Robert A. Vierkant(Mayo Clinic), George Au‐Yeung(The University of Melbourne), Anna DeFazio(The University of Sydney), Stacey J. Winham(Mayo Clinic), Kathryn Alsop(Peter MacCallum Cancer Centre), Elizabeth L. Christie(Peter MacCallum Cancer Centre), Pamela Provan(The University of Sydney), Catherine J. Kennedy(The University of Sydney), Susan J. Ramus(Cancer Institute of New South Wales), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Joy Hendley(Peter MacCallum Cancer Centre), Phineas T. Hamilton, Sián Fereday(Peter MacCallum Cancer Centre), Brad H. Nelson(University of British Columbia), Yoke-Eng Chiew(The University of Sydney), Malcolm C. Pike(Kettering University), Ahwan Pandey(Howard Hughes Medical Institute), Paul R. Harnett(The University of Sydney), Alison H. Brand(The University of Sydney), Thomas P. Conrads(Inova Health System), Leanne Bowes(Peter MacCallum Cancer Centre), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Orla McNally(Royal Women's Hospital), Dinuka Ariyaratne(Peter MacCallum Cancer Centre), Chen Wang(Xiamen University), Anna Piskorz(Cancer Research UK Cambridge Center), Nadia Traficante(The University of Melbourne), Jillian A. Hung(Millennium Institute), Celeste Leigh Pearce(University of Southern California)
Cited by 115
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k